Quarter Period Statement Of Income

Carna Biosciences, Inc. - Filing #7568781

Concept 2023-01-01 to
2023-03-31
2023-01-01 to
2023-03-31
2023-01-01 to
2023-03-31
2022-01-01 to
2022-03-31
2022-01-01 to
2022-03-31
2022-01-01 to
2022-03-31
Quarter period statement of income
Statement of income
Net sales
226,967,000 JPY
JPY
226,967,000 JPY
554,650,000 JPY
286,045,000 JPY
268,605,000 JPY
Cost of sales
48,635,000 JPY
42,483,000 JPY
Gross profit (loss)
178,332,000 JPY
512,167,000 JPY
Selling, general and administrative expenses
684,125,000 JPY
511,032,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
-505,792,000 JPY
-570,136,000 JPY
64,343,000 JPY
1,135,000 JPY
-107,969,000 JPY
109,105,000 JPY
Non-operating income
Interest income
64,000 JPY
44,000 JPY
Dividend income
105,000 JPY
101,000 JPY
Non-operating income
193,000 JPY
5,944,000 JPY
Non-operating expenses
Interest expenses
896,000 JPY
1,634,000 JPY
Non-operating expenses
7,769,000 JPY
2,502,000 JPY
Ordinary profit (loss)
-513,368,000 JPY
4,576,000 JPY
Extraordinary losses
Impairment losses
462,000 JPY
15,386,000 JPY
Extraordinary losses
462,000 JPY
15,386,000 JPY
Profit (loss) before income taxes
-513,831,000 JPY
-10,809,000 JPY
Income taxes - current
5,407,000 JPY
4,325,000 JPY
Income taxes - deferred
-28,000 JPY
-30,000 JPY
Income taxes
5,378,000 JPY
4,295,000 JPY
Profit (loss)
-519,210,000 JPY
-15,104,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.